TIMM9作为多种癌症及其相关生物过程的预后生物标志物
Lisheng Zhang1, Yan Huang1, Yanting Yang1
1School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, 232 Outer Ring East Road, Guangzhou University City, Panyu District, Guangzhou, 510006, Guangdong, China.
Scientific reports
|September 4, 2024
概括
过度表达TIMM9与癌症进展和不良预后相关. 这种线粒体蛋白影响细胞循环,免疫力和新陈代谢,ITFG1被确定为关键的相互作用蛋白.
科学领域:
- 线粒体生物学 线粒体生物学
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
背景情况:
- 确定了TIMM9 (TIMM9) 在线粒体功能中的作用,但其在胰腺癌中的重要性尚不清楚.
- 了解TIMM9在各种癌症中的参与对于开发新型治疗策略至关重要.
研究的目的:
- 通过综合生物信息学,计算化学和实验方法研究TIMM9在泛癌症中的多方面的作用.
- 阐明TIMM9表达,遗传变化及其调节途径与癌症发展和患者结果的关联.
主要方法:
- 大规模癌症数据集的生物信息分析.
- 计算化学技术,包括分子模拟.
- 主要发现的实验验证.
主要成果:
- 过度表达TIMM9与增加瘤发生,晚期病理阶段和转移有关.
- 误解突变 (例如S49L),拷贝数变异 (CNVs) 和TIMM9中的甲基化变化与癌症预后不佳相关.
- TIMM9积极影响细胞循环,线粒体和核糖体功能,氧化酸化,TCA循环活性,以及先天性和适应性免疫.
- TIMM9受癌症相关途径的调节,如mTOR.
- 分子模拟确定ITFG1是TIMM9最强的结合伙伴,这表明存在显著的结构相互作用.
结论:
- TIMM9是泛癌的关键调解者,影响瘤进展,细胞功能和免疫反应.
- 在TIMM9的遗传和表观遗传改变作为潜在的预后生物标志物.
- 发现的TIMM9和ITFG1之间的相互作用为未来的癌症疗法提供了潜在的标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


